NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
GlobeNewswire
· Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands..
Live PD
News and Video Search Results
News coverage
-
Anthos Therapeutics Announces Appointment of Bill Meury as CEO
GlobeNewswire
-
SmallRig has unveiled a line of innovative products, co-designed with professional creators at 2024 NAB Show
PR Newswire Asia
-
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire
-
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
GlobeNewswire
0 shares
1 views
You might like
Live PD media coverage
Vanqua Bio Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating VQ-101, its Small Molecule GCase Activator for GBA-Parkinson’s Disease and Related Disorders
GlobeNewswire
- VQ-101 is a potent allosteric activator of glucocerebrosidase (GCase)
- The Phase 1 program aims to demonstrate VQ-101’s..
-
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
GlobeNewswire
-
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
GlobeNewswire
-
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire
-
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
GlobeNewswire
Advertisement
More coverage
Affimed Reports 2023 Financial Results and Operational Progress
GlobeNewswire
· *AFM24 combination with atezolizumab (AFM24-102):* Follow-up of the Phase 1/2a combination study confirmed four responses in the..
-
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
GlobeNewswire
-
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
GlobeNewswire
-
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY
PR Newswire Asia
-
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
GlobeNewswire